U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07216742) titled 'Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.' on Oct. 02.

Brief Summary: The goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reproductive Technology (ART) cycle in in women with a diagnosis of infertility.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Infertility (IVF Patients)

Intervention: DRUG: hMG subcutaneous injec...